Registered Clinical Studies Investigating Psychedelic Drugs for Psychiatric Disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Registered Clinical Studies Investigating Psychedelic Drugs for Psychiatric Disorders
Authors
Keywords
Psychedelics, MDMA, Psilocybin, Psychiatric disorders, Depression, Post-traumatic stress disorder, LSD, DMT, Ayahuasca, Ibogaine
Journal
JOURNAL OF PSYCHIATRIC RESEARCH
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-18
DOI
10.1016/j.jpsychires.2021.05.019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psychedelics and Psychedelic-Assisted Psychotherapy
- (2020) Collin M. Reiff et al. AMERICAN JOURNAL OF PSYCHIATRY
- The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
- (2020) Simon B. Goldberg et al. PSYCHIATRY RESEARCH
- Registered clinical trials investigating ketamine for psychiatric disorders
- (2020) Bahareh Peyrovian et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
- (2020) Joost J. Breeksema et al. CNS DRUGS
- The emerging role of psilocybin and MDMA in the treatment of mental illness
- (2020) Hartej Gill et al. Expert Review of Neurotherapeutics
- A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
- (2019) Ben Sessa et al. Frontiers in Psychiatry
- The next generation of therapy for multiple myeloma: a review of ongoing clinical trials utilizing ClinicalTrials.gov
- (2018) Peter Barth et al. Future Oncology
- Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy
- (2018) Taylor R Cushman et al. Immunotherapy
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
- (2018) Rafael G. dos Santos et al. Expert Review of Clinical Pharmacology
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- Psychedelic Drugs in Biomedicine
- (2017) Evan J. Kyzar et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ayahuasca: Pharmacology, neuroscience and therapeutic potential
- (2016) Elisabet Domínguez-Clavé et al. BRAIN RESEARCH BULLETIN
- The hallucinogenic world of tryptamines: an updated review
- (2015) Ana Margarida Araújo et al. ARCHIVES OF TOXICOLOGY
- Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration
- (2009) G. J. H. Dumont et al. Social Neuroscience
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started